Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Damien Toulorge"'
Publikováno v:
Cells, Vol 9, Iss 2, p 471 (2020)
Neurodegenerative diseases are characterized by neuronal degeneration as well as neuroinflammation. While CD38 is strongly expressed in brain cells including neurons, astrocytes as well as microglial cells, the role played by CD38 in neurodegeneratio
Externí odkaz:
https://doaj.org/article/33c61c72ae934127b8512919c3517b69
Publikováno v:
Journal of Neurochemistry. 139:27-58
Parkinson disease (PD) is the second most common neurodegenerative disease after Alzheimer disease. Although PD has a relatively narrow clinical phenotype, it has become clear that its etiological basis is broad. Post-mortem brain analysis, despite i
Publikováno v:
The FASEB Journal. 27:3414-3423
Parkinson disease (PD) is a degenerative brain disorder characterized by motor symptoms that are unequivocally associated with the loss of dopaminergic (DA) neurons in the substantia nigra (SN). Although our knowledge of the mechanisms that contribut
Publikováno v:
Journal of Neurochemistry. 114:553-564
While K(ATP) channels serve primarily as metabolic gatekeepers in excitable cells, they might also participate in other important cellular functions. Here, we demonstrate that K(ATP) channel blockade with the sulfonylurea derivative glibenclamide pro
Autor:
Serge Guerreiro, Damien Toulorge, Patrick P. Michel, Daniel Alvarez-Fischer, Etienne C. Hirsch, Aurélie Ponceau, Elodie Martin
Publikováno v:
Journal of Neurochemistry. 109:1118-1128
High plasma levels of the end product of purine metabolism uric acid (UA) predict a reduced risk of developing Parkinson's disease suggesting that UA may operate as a protective factor for midbrain dopaminergic neurons. Consistent with this view, UA
Autor:
Julie Foucquier, Sandra Robelet, Mickaël Guedj, Julien Laffaire, Ilya Chumakov, Daniel Cohen, Rodolphe Hajj, Richard Mitry, Damien Toulorge, Nathalie Cholet, Serguei Nabirotchkin, Aude Milet
Publikováno v:
Scientific Reports
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterised by the loss of dopaminergic nigrostriatal neurons but which involves the loss of additional neurotransmitter pathways. Mono- or polytherapeutic interventions in PD p
Autor:
Emmanuel Vial, Damien Toulorge, Nathalie Cholet, Yannick Pereira, Rémy Steinschneider, Esther Graudens, Tangui Maurice, Julie Foucquier, Rodolphe Hajj, Ilya Chumakov, Serguei Nabirotchkin, Aude Milet, Daniel Cohen, Catherine Scart-Grès, Aurélie Boucard, Noelle Callizot, Mickaël Guedj, Sory Traoré, Viviane Bertrand
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, 2015, 5 (1), ⟨10.1038/srep07608⟩
Alzheimer disease (AD) represents a major medical problem where mono-therapeutic interventions demonstrated only a limited efficacy so far. We explored the possibility of developing a combinational therapy that might prevent the degradation of neuron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97b170dd001135da9749208d50aa097
https://hal.archives-ouvertes.fr/hal-01922611
https://hal.archives-ouvertes.fr/hal-01922611
Autor:
Serge Guerreiro, Audrey Hild, Uwe Maskos, Etienne C. Hirsch, Patrick P. Michel, Damien Toulorge
Publikováno v:
FASEB Journal
FASEB Journal, Federation of American Society of Experimental Biology, 2011, 25 (8), pp.2563-2573. ⟨10.1096/fj.11-182824⟩
FASEB Journal, 2011, 25 (8), pp.2563-2573. ⟨10.1096/fj.11-182824⟩
FASEB Journal, Federation of American Society of Experimental Biology, 2011, 25 (8), pp.2563-2573. ⟨10.1096/fj.11-182824⟩
FASEB Journal, 2011, 25 (8), pp.2563-2573. ⟨10.1096/fj.11-182824⟩
International audience; Epidemiological and experimental evidence indicates that nicotine is protective for Parkinson disease vulnerable dopamine neurons, but the underlying mechanism of this effect remains only partly characterized. To address this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe983786ed6f0f549846665d2f38a730
https://hal-pasteur.archives-ouvertes.fr/pasteur-02936389
https://hal-pasteur.archives-ouvertes.fr/pasteur-02936389
Publikováno v:
Journal of neurochemistry. 114(2)
While K(ATP) channels serve primarily as metabolic gatekeepers in excitable cells, they might also participate in other important cellular functions. Here, we demonstrate that K(ATP) channel blockade with the sulfonylurea derivative glibenclamide pro
Autor:
Serge Guerreiro, Damien Toulorge, Etienne C. Hirsch, Marc Marien, Patrick P. Michel, Pierre Sokoloff
Publikováno v:
Molecular pharmacology. 74(4)
Epidemiological evidence suggests that caffeine or its metabolites reduce the risk of developing Parkinson's disease, possibly by protecting dopaminergic neurons, but the underlying mechanism is not clearly understood. Here, we show that the primary